THESEUS PHARMACEUTICALS, INC. THRX 深 沪
已收盘 02-26 16:00:00 美东时间
4.06
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 4.06
- 总市值 1.80亿
- 52周最高 12.37
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.05
- 委 比 0.00%
- 总股本 4423.01万
- 历史最高 24.54
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.05
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX
NEW YORK, Dec. 22, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2023-12-23 01:26
Small-Cap Cancer Focused Theseus Pharmaceuticals Goes Private For Over $3.90/Share In Cash
Theseus Pharmaceuticals Inc (NASDAQ: THRX) on Friday, has entered into a definitive merger agreement whereby Concentra Biosciences LLC will acquire Theseus for a price per share of between $3.90 and $4.05 in cash, consisting of a base cash price of $3.90 per share and an addi
2023-12-22 21:58
Crude Oil Moves Higher; Beauty Health Shares Plunge
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 500 points on Tuesday. The Dow traded up 1.42% to 34,833.89 while the NASDAQ rose 2.34% to 14,089.95. The S&P 500 also rose, gaining, 1.93% to 4,496.87.
2023-11-15 02:11
Nasdaq Surges 2%; US Inflation Rate Slows In October
U.S. stocks traded higher this morning, with the Dow Jones gaining around 400 points on Tuesday. Following the market opening Tuesday, the Dow traded up 1.16% to 34,736.95 while the NASDAQ rose 2.03% to 14,047.59. The S&P 500 also rose, gaining, 1.61% to 4,482.49.
2023-11-14 22:50
Market-Moving News for November 14th
THRX: 53% | Theseus Pharmaceuticals Announces Process To Explore Strategic Alternatives BCDA: 166% | Biocardia Announced The FDA Approval Of Its Phase 3 Clinical Trial Of Its CardiAMP Autologous Cell
2023-11-14 21:41
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
CAMBRIDGE, Mass., Nov. 13, 2023 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the liv...
2023-11-14 05:05
Deciphera Pharmaceuticals Sees Renewed Competitive Edge After Theseus Pan-KIT Discontinuation: Analyst
Stifel upgraded Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) to Buy from Hold, with a price target of $20 from $14, after reevaluating the competitive landscape for the 2L GIST market.
2023-08-11 02:09
Stocks to Consider: Knightscope, Mullen Automotive, Nikola, Ideanomics, or Theseus Pharmaceuticals
InvestorsObserver has issued critical PriceWatch Alerts for several stocks, inc...
2023-07-21 23:49
$2M Bet On Molecular Templates? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed higher by more than 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
2023-07-20 20:58
